Penumbra, Inc.
United States
175 articles with Penumbra, Inc.
-
Penumbra and Asahi Intecc Partner With Goal of Introducing Indigo™ System Including Lightning™ Intelligent Aspiration to Japan
9/22/2022
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo™ Aspiration System into the Japanese market upon regulatory approval.
-
In a season that has seen painful layoffs for many biopharma companies, BioSpace had more registrations in August than in any other month this year. This is indicative of a competitive job market.
-
Penumbra Announces European Launch of RED® Reperfusion Catheters for Stroke Care
9/7/2022
Penumbra, Inc., a global healthcare company focused on innovative therapies, announced that its RED® Reperfusion Catheters have secured CE Mark and are now commercially available in Europe.
-
Latest Data Demonstrates Penumbra System and RED® Reperfusion Catheters Effective for Broad Stroke Care
8/25/2022
Penumbra, Inc., a global healthcare company focused on innovative therapies, announced initial INSIGHT Registry data showing Penumbra’s RED® reperfusion catheters were successful in removing all clot types.
-
Penumbra, Inc. to Present at Upcoming Investor Conferences in September 2022
8/24/2022
Penumbra, Inc. announced that its management team is scheduled to present at the following investor conferences.
-
Penumbra, Inc. Reports Second Quarter 2022 Financial Results
8/4/2022
Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the second quarter ended June 30, 2022.
-
Penumbra, Inc. to Present at the Canaccord Genuity 42nd Annual Growth Conference
7/27/2022
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022.
-
Penumbra, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 4, 2022
7/7/2022
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2022 after market close on Thursday, August 4, 2022 at 4:30 PM Eastern Time.
-
Penumbra, Inc. Reports First Quarter 2022 Financial Results
5/3/2022
Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the first quarter ended March 31, 2022.
-
Penumbra, Inc. to Present at the Bank of America Securities 2022 Healthcare Conference
4/26/2022
Penumbra, Inc. announced that its management team is scheduled to present at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, 2022.
-
Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration
4/14/2022
Penumbra, Inc., a global healthcare company focused on innovative therapies, announced that its Indigo Aspiration System with Lightning 7 and Lightning 12 have secured CE Mark and are now commercially available in Europe.
-
Penumbra, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 3, 2022
4/5/2022
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2022 after market close on Tuesday, May 3, 2022 at 4:30 PM Eastern Time.
-
Penumbra, Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
3/28/2022
Penumbra, Inc. announced that its management team is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022.
-
Penumbra, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
2/22/2022
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2021.
-
Penumbra, Inc. to Present at Citi's 2022 Virtual Healthcare Conference
2/10/2022
Penumbra, Inc. announced that its management team is scheduled to present at Citi's 2022 Virtual Healthcare Conference on Thursday, February 24, 2022.
-
Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
12/22/2021
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.
-
New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
11/5/2021
New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo ® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
-
Penumbra, Inc. Reports Third Quarter 2021 Financial Results
11/3/2021
Penumbra, Inc. today reported financial results for the third quarter ended September 30, 2021 .
-
Penumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021
10/6/2021
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2021 after market close on Wednesday, November 3, 2021 at 4:30 PM Eastern Time.
-
Penumbra, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
8/31/2021
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021.